Munafa Stock Market Course + Intraday & FNO calls 
GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
GLENMARK NEWS reasons for why stock price of Glenmark Pharmaceuticals Limited is falling or rising
GLENMARK Glenmark Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast for Glenmark Pharmaceuticals Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Glenmark Pharmaceuticals GLENMARK at this time. Stock is falling and might fall more.
It appears as if Glenmark Pharmaceuticals GLENMARK gave a large move recently.
Stock of Glenmark Pharmaceuticals (GLENMARK) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...
My analysis of Glenmark Pharmaceuticals is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Glenmark Pharmaceuticals stays below 1960.2, but if it comes above 1960.2, then a intra day buy could be more profitable.
If you take a sell trade below 1960.2, then use 1960.2 as stoploss and 1910.9 as target. However if you take a buy trade in Glenmark Pharmaceuticals, then use 1960.2 as stoploss and 2001.31 as target.
GLENMARK Glenmark Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2026-01-20
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about ESG Rating. - NEWS as on 2026-01-06
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, - NEWS as on 2025-12-23
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 16, 2025, titled "Glenmark Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma" - NEWS as on 2025-12-16
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial". - NEWS as on 2025-12-11
Company Announcement Update on the Company's Chhatrapati Sambhajinagar (Aurangabad) Facility - NEWS as on 2025-12-01
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility". - NEWS as on 2025-11-27
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 25, 2025, titled "Glenmark Pharmaceuticals Announces Launch of Nebzmart® GFB Smartules® and Glenmark - NEWS as on 2025-11-25
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2025-11-20
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 18, 2025, titled "Cosmo and Glenmark Announce Market Authorization of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 15 countries in Europe - NEWS as on 2025-11-18
Company Announcement Glenmark Pharmaceuticals Limited has submitted to the Exchange, Unaudited Financial Results (Standalone and Consolidated) for the Second Quarter and Half Year - NEWS as on 2025-11-17
More announcements and NEWS
GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals
Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 21 Wed Jan 2026 | 1941.40 | 1910.10 to 1960.00 | 0.33% | 0.93 times |
| 20 Tue Jan 2026 | 1935.00 | 1927.40 to 1989.80 | -2.75% | 0.82 times |
| 19 Mon Jan 2026 | 1989.80 | 1980.30 to 2007.40 | -0.54% | 0.32 times |
| 16 Fri Jan 2026 | 2000.70 | 1990.00 to 2028.00 | -0.53% | 0.72 times |
| 14 Wed Jan 2026 | 2011.30 | 2003.30 to 2041.80 | 0.15% | 1.03 times |
| 13 Tue Jan 2026 | 2008.20 | 1951.10 to 2028.00 | -0.46% | 1.66 times |
| 12 Mon Jan 2026 | 2017.50 | 1967.60 to 2020.40 | 0.51% | 0.7 times |
| 09 Fri Jan 2026 | 2007.20 | 1997.00 to 2079.00 | -3.49% | 0.94 times |
| 08 Thu Jan 2026 | 2079.80 | 2074.00 to 2122.10 | -1.58% | 0.82 times |
| 07 Wed Jan 2026 | 2113.10 | 2070.70 to 2147.50 | 1.86% | 2.55 times |
| 06 Tue Jan 2026 | 2074.60 | 2031.50 to 2080.80 | 1.74% | 0.45 times |
| 05 Mon Jan 2026 | 2039.20 | 2031.50 to 2091.80 | -1.23% | 0.66 times |
Videos related to: GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
